INHIBITORS OF TYROSINE PHOSPHORYLATION INDUCE APOPTOSIS IN HUMAN LEUKEMIC-CELL LINES

被引:0
|
作者
BERGAMASCHI, G
ROSTI, V
DANOVA, M
PONCHIO, L
LUCOTTI, C
CAZZOLA, M
机构
[1] IRCCS, POLICLIN S MATTEO, DEPT INTERNAL MED & MED THERAPY, MED CLIN 2, I-27100 PAVIA, ITALY
[2] UNIV PAVIA, PAVIA, ITALY
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Experimental evidence suggests that hematopoietic growth factors promote cell survival by suppressing apoptosis or programmed cell death. Since interleukin 3 (IL-3) and granulocyte-macrophage colony stimulating factor (GM-CSF) induce tyrosine phosphorylation of a common set of proteins in the factor-dependent cell line M07e, we have investigated whether growth-factor-induced tyrosine phosphorylation is involved in the promotion of cell survival and suppression of apoptosis. Experiments were carried out with the leukemic cell lines HL-60 and M07e and the tyrosine kinase inhibitors genistein and tyrphostin AG82. Both the tyrosine kinase inhibitors induced apoptosis of HL-60 and M07e cells. This was indicated by the appearance of DNA degradation and morphologic evidence of nuclear condensation and fragmentation. It was also confirmed by flow cytometry of DNA, which showed apoptotic cells as a fraction of cells characterized by a diminished DNA stainability, represented on the DNA frequency histograms as a distinct peak below the G(0)/G(1) population. Kinase inhibitors also reduced the fraction of cells in the S phase of the cell cycle. That tyrphostin specifically inhibited tyrosine kinases was further suggested by the prevention of its effects by the tyrosine phosphatase inhibitor sodium orthovanadate (vanadate), at least during the first 18-24 h of treatment. The incomplete prevention of genistein effects by vanadate suggests that genistein is a less specific inhibitor of tyrosine kinases than tyrphostin, and may also act as an inhibitor of topoisomerase it. Vanadate also prevented apoptosis and reduction of the S phase in M07e cells cultured for 24 h in the absence of growth factors. These results suggest that tyrosine phosphorylation is an essential step in IL-3 and GM-CSF signal transduction. Since in our experimental model the effects of tyrosine kinase inhibition and growth factor deprivation could be reversed by concomitant inhibition of tyrosine phosphatases, it is suggested that a balance between tyrosine kinases and tyrosine phosphatases establishes whether a cell will survive or undergo apoptosis.
引用
收藏
页码:2012 / 2018
页数:7
相关论文
共 50 条
  • [1] ANTIMICROTUBULE AGENTS INDUCE POLYPLOIDIZATION OF HUMAN LEUKEMIC-CELL LINES WITH MEGAKARYOCYTIC FEATURES
    VANDERLOO, B
    HONG, Y
    HANCOCK, V
    MARTIN, JF
    ERUSALIMSKY, JD
    [J]. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1993, 23 (10) : 621 - 629
  • [2] EXPRESSION OF THE SERGLYCIN GENE IN HUMAN LEUKEMIC-CELL LINES
    MAILLET, P
    ALLIEL, PM
    MITJAVILA, MT
    PERIN, JP
    JOLLES, P
    BONNET, F
    [J]. LEUKEMIA, 1992, 6 (11) : 1143 - 1147
  • [3] BINDING OF LECTINS TO LEUKEMIC-CELL LINES
    SCHWENK, HU
    SCHNEIDER, U
    HERZOG, KH
    [J]. BLUT, 1980, 40 (01): : 7 - 15
  • [4] EXPRESSION OF P53 IN HUMAN LEUKEMIC-CELL LINES
    KRAISS, S
    ESPIG, R
    VETTER, U
    HARTMANN, W
    MONTENARH, M
    [J]. LEUKEMIA RESEARCH, 1990, 14 (11-12) : 1041 - 1051
  • [5] SYNTHESIS OF TISSUE FACTOR IN LEUKEMIC-CELL LINES
    SATO, N
    TAKAHASHI, H
    KISHI, K
    SHIBATA, A
    [J]. THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1182 - 1182
  • [6] THE ROLE OF CALCIUM IN DIFFERENTIATION OF LEUKEMIC-CELL LINES
    REPHAELI, A
    AVIRAM, A
    RABIZADEH, E
    ENGLENDER, T
    SHAKLAI, M
    [J]. CANCER BIOCHEMISTRY BIOPHYSICS, 1990, 11 (02): : 119 - 125
  • [7] DIFFERENTIAL SENSITIVITY OF LEUKEMIC-CELL LINES TO NITROBENZYLTHIOINOSINE
    CASS, CE
    PETEYA, DJ
    LYNCH, MA
    TUPAS, J
    JANMOHAMED, N
    JANOWSKAWIECZOREK, A
    [J]. BONE MARROW TRANSPLANTATION, 1987, 2 : 124 - 124
  • [8] PHENOTYPIC CHARACTERISTICS OF RAT LEUKEMIC-CELL LINES
    GREINER, D
    BARTON, R
    REYNOLDS, C
    GOLDSCHNEIDER, I
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1981, 22 (MAR): : 324 - 324
  • [9] PLASMINOGEN ACTIVATORS AND THEIR INHIBITORS IN LEUKEMIC-CELL HOMOGENATES
    WADA, H
    KUMEDA, Y
    OGASAWARA, Z
    OHIWA, M
    KANEKO, T
    TAMAKI, S
    OHNO, T
    KAGEYAMA, S
    KOBAYASHI, T
    DEGUCHI, K
    SHIRAKAWA, S
    [J]. AMERICAN JOURNAL OF HEMATOLOGY, 1993, 42 (02) : 166 - 170
  • [10] 5-NITROFURAN DERIVATIVES OF FATTY-ACID HYDRAZIDES INDUCE DIFFERENTIATION IN HUMAN MYELOID LEUKEMIC-CELL LINES
    SUR, P
    CHATTERJEE, S
    ROY, P
    SUR, B
    [J]. CANCER LETTERS, 1995, 94 (01) : 27 - 32